ADAM SHAFER: Open Payments
NPI 1427451384 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 14 payments from 6 companies in 2025. Trend: 2023 $770 · 2024 $542 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $206 |
| Janssen Pharmaceuticals, Inc | 2 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Alkermes, Inc. | 2 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: UZEDY, INVEGA SUSTENNA, CAPLYTA, ARISTADA, INGREZZA, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
